if pancreatitis is suspected, do not take any further doses and seek urgent medical assessment immediately [15] [16] Pain in the upper right abdomen, or yellowing of the skin or whites of the eyes (jaundice) these may indicate gallbladder disease, a risk associated with rapid weight loss and GLP-1 receptor agonist use [16] [17] Fever accompanying diarrhoea, which may suggest an infective cause requiring separate investigation Significant unintentional weight loss beyond what is expected from the treatment For people with type 2 diabetes: persistent diarrhoea can reduce carbohydrate absorption and increase the risk of hypoglycaemia, particularly if insulin or sulphonylureas are co-prescribed
The Future of GLP-1 Therapy in India In India, semaglutide and liraglutide are now available for both diabetes and obesity treatment
Based on Women Hair Growth Nutraceutical Backed by science
Endocr Rev 2008;29:36779.PubMedPMC 34
What makes our program unique is our focus on more than just the scale
Such studies are inherently susceptible to confounding by socioeconomic status, access to healthcare, reimbursement policies, and patient adherence, all of which may significantly impact treatment continuation and metabolic outcomes
